These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 20049800
21. Cell-penetrating peptides: breaking through to the other side. Koren E, Torchilin VP. Trends Mol Med; 2012 Jul; 18(7):385-93. PubMed ID: 22682515 [Abstract] [Full Text] [Related]
22. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles. Winter PM, Cai K, Caruthers SD, Wickline SA, Lanza GM. Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221 [Abstract] [Full Text] [Related]
24. Properties of cell penetrating peptides (CPPs). Kerkis A, Hayashi MA, Yamane T, Kerkis I. IUBMB Life; 2006 Jan; 58(1):7-13. PubMed ID: 16540427 [Abstract] [Full Text] [Related]
25. Chemically modified cell-penetrating peptides for the delivery of nucleic acids. Mäe M, Andaloussi SE, Lehto T, Langel U. Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582 [Abstract] [Full Text] [Related]
26. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Tan ML, Choong PF, Dass CR. Peptides; 2010 Jan; 31(1):184-93. PubMed ID: 19819278 [Abstract] [Full Text] [Related]
27. [Inhalative pharmacotherapy in the future--nanocarriers for pulmonary drug delivery]. Gessler T. Pneumologie; 2009 Dec; 63 Suppl 2():S113-6. PubMed ID: 20013540 [Abstract] [Full Text] [Related]
28. Cell-penetrating peptides in drug development: enabling intracellular targets. Chen L, Harrison SD. Biochem Soc Trans; 2007 Aug; 35(Pt 4):821-5. PubMed ID: 17635156 [Abstract] [Full Text] [Related]
29. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. Wang F, Wang Y, Zhang X, Zhang W, Guo S, Jin F. J Control Release; 2014 Jan 28; 174():126-36. PubMed ID: 24291335 [Abstract] [Full Text] [Related]
30. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy". Shi NQ, Qi XR, Xiang B, Zhang Y. J Control Release; 2014 Nov 28; 194():53-70. PubMed ID: 25151981 [Abstract] [Full Text] [Related]
31. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art. Moutinho CG, Matos CM, Teixeira JA, Balcão VM. J Drug Target; 2012 Feb 28; 20(2):114-41. PubMed ID: 22023555 [Abstract] [Full Text] [Related]
32. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. Dissanayake S, Denny WA, Gamage S, Sarojini V. J Control Release; 2017 Mar 28; 250():62-76. PubMed ID: 28167286 [Abstract] [Full Text] [Related]
33. Classes and prediction of cell-penetrating peptides. Lindgren M, Langel U. Methods Mol Biol; 2011 Mar 28; 683():3-19. PubMed ID: 21053118 [Abstract] [Full Text] [Related]
34. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Zorko M, Langel U. Adv Drug Deliv Rev; 2005 Feb 28; 57(4):529-45. PubMed ID: 15722162 [Abstract] [Full Text] [Related]
38. Self-assembly of drug-loaded liposomes on genetically engineered target-recognizing M13 phage: a novel nanocarrier for targeted drug delivery. Ngweniform P, Abbineni G, Cao B, Mao C. Small; 2009 Sep 10; 5(17):1963-9. PubMed ID: 19415651 [No Abstract] [Full Text] [Related]
39. Biological responses towards cationic peptides and drug carriers. Verdurmen WP, Brock R. Trends Pharmacol Sci; 2011 Feb 10; 32(2):116-24. PubMed ID: 21167610 [Abstract] [Full Text] [Related]